浏览全部资源
扫码关注微信
- Journal Information
- Archive
- Submission
- For Reviewers
- Statement and Policies
Systematic review of the economic evaluation of influenza vaccines in the Guangdong-Hong Kong-Macao Greater Bay Area
- ZHONGGUO YAOFANG Vol. 34, Issue 6, Pages: 699-703(2023)
- 作者机构：
1.北京大学公共卫生学院，北京 100191
2.北京大学中国卫生发展研究中心，北京 100191
- 作者简介：
- 基金信息：
DOI：10.6039/j.issn.1001-0408.2023.06.11
CLC： R956Published：30 March 2023，
Received：18 October 2022，
Revised：10 February 2023，
扫 描 看 全 文
胡明政,王延赏,王明等.我国粤港澳大湾区流感疫苗经济学评价的系统分析 Δ[J].中国药房,2023,34(06):699-703.
HU Mingzheng,WANG Yanshang,WANG Ming,et al.Systematic review of the economic evaluation of influenza vaccines in the Guangdong-Hong Kong-Macao Greater Bay Area[J].ZHONGGUO YAOFANG,2023,34(06):699-703.
胡明政,王延赏,王明等.我国粤港澳大湾区流感疫苗经济学评价的系统分析 Δ[J].中国药房,2023,34(06):699-703. DOI： 10.6039/j.issn.1001-0408.2023.06.11.
HU Mingzheng,WANG Yanshang,WANG Ming,et al.Systematic review of the economic evaluation of influenza vaccines in the Guangdong-Hong Kong-Macao Greater Bay Area[J].ZHONGGUO YAOFANG,2023,34(06):699-703. DOI： 10.6039/j.issn.1001-0408.2023.06.11.
摘要
目的
2
系统分析我国粤港澳大湾区流感疫苗卫生经济学评价的研究现状，为今后学者开展粤港澳大湾区流感疫苗经济性评价提供方法学参考。
方法
2
计算机检索PubMed、Embase等7个英文数据库和中国知网、万方数据等3个中文数据库，收集研究地区为粤港澳大湾区的流感疫苗卫生经济学评价研究，检索时限为建库起至2022年6月30日。筛选文献、提取信息后，对纳入文献的研究设计、评价方法、模型情况、经济学评价结果与结论进行描述性分析，并采用卫生经济研究质量评价工具对文献质量进行评价。
结果
2
共纳入12篇文献，其中7篇的研究地区为中国香港，6篇的目标群体为老年群体，5篇的研究角度为全社会角度，研究时限从6个月到9年不等。有8篇文献采用了成本-效用分析法，仅有2篇使用了传染病模型。有8篇文献进行了敏感性分析，且大部分文献同时进行了单因素敏感性分析和概率敏感性分析。有10篇文献的评价结果表明，（联合）接种疫苗或提高疫苗接种率的方案更具经济性。12篇文献中，有4篇的质量评分＞75分，属于高质量研究。
结论
2
尽管大部分的纳入研究都显示接种疫苗具有经济性，但现有文献的质量有待提升。建议后续开展大湾区流感疫苗经济学评价时，可考虑增加针对我国澳门和广东省其他城市的经济学评价，优先选用动态模型和本地居民的近期数据，并参考相关工具、指南，以提高研究设计的规范性和科学性。
Abstract
OBJECTIVE
2
To systematically analyze the status of health economic evaluation studies of influenza vaccination in Guangdong-Hong Kong-Macao Greater Bay Area （GBA） of China， and to provide a methodological reference for future scholars to carry out economic evaluations of influenza vaccine in GBA.
METHODS
2
Seven English databases such as PubMed and Embase and three Chinese databases such as CNKI and Wanfang database were searched. The economic evaluation studies of influenza vaccines with the study area of GBA were collected. The search time frame was from the inception to June 30， 2022. After screening the literature and extracting key information， descriptive analysis was conducted on the study design， evaluation methods， model settings， results and conclusions of these collected papers， and the quality of the papers was evaluated using Quality of Health Economic Studies.
RESULTS
2
A total of 12 papers were included， of which 7 had a study region of Hong Kong in China， 6 had an older target group， 5 had a society-wide perspective， and the study time frame ranged from 6 months to 9 years. Besides， 8 papers used cost-utility analysis， only 2 used an epidemic model； 8 papers conducted sensitivity analyses， and most of them conducted both one-way sensitivity analysis and probabilistic sensitivity analysis. Moreover， the results of the economic evaluation of 10 papers showed that （combined） vaccination or increased vaccination rates were more economical. In addition， 4 of the 12 papers had a quality score＞75， which were considered high-quality studies.
CONCLUSIONS
2
Although most of the included studies showed that vaccination was economical， the quality of the existing paper needed to be improved. It is recommended that subsequent studies on the economic evaluation of influenza vaccines in GBA may consider adding economic evaluations for Macau and other cities in Guangdong of China， prioritizing dynamic models and recent data from local residents， and referring to relevant tools and guidelines to improve the standardization and scientificity of the study design.
关键词
粤港澳大湾区流感疫苗经济学评价系统分析
Keywords
influenza vaccineeconomic evaluationsystematic review
references
GAITONDE D Y，MOORE F C，MORGAN M K. In-fluenza：diagnosis and treatment[J]. Am Fam Physician，2019，100（12）：751-758.
SOMES M P，TURNER R M，DWYER L J，et al. Estima-ting the annual attack rate of seasonal influenza among unvaccinated individuals：a systematic review and meta-analysis[J]. Vaccine，2018，36（23）：3199-3207.
WANG Q，YUE N，ZHENG M Y，et al. Influenza vaccination coverage of population and the factors influencing influenza vaccination in mainland China：a meta-analysis[J]. Vaccine，2018，36（48）：7262-7269.
孟庆跃. 卫生经济学[M]. 北京：人民卫生出版社，2012：301-325.
YANG J，ATKINS K E，FENG L Z，et al. Cost-effectiveness of introducing national seasonal influenza vaccination for adults aged 60 years and above in mainland China：a modelling analysis[J]. BMC Med，2020，18（1）：90.
新华社. 中共中央 国务院印发《粤港澳大湾区发展规划纲要》[J]. 中华人民共和国国务院公报，2019（7）：4-25.
JONES R M. Critical review and uncertainty analysis of factors influencing influenza transmission[J]. Risk Anal，2011，31（8）：1226-1242.
TURNER D，WAILOO A，NICHOLSON K，et al. Sys-tematic review and economic decision modelling for the prevention and treatment of influenza A and B[J]. Health Technol Assess，2003，7（35）：Ⅲ-Ⅳ，Ⅺ-，1-170.
THACKER S B. The persistence of influenza A in human populations[J]. Epidemiol Rev，1986，8：129-142.
SCHAFFER F L，SOERGEL M E，STRAUBE D C. Survival of airborne influenza virus：effects of propagating host，relative humidity，and composition of spray fluids[J]. Arch Virol，1976，51（4）：263-273.
ZHU A Q，ZHENG Y M，QIN Y，et al. A systematic review of the economic burden of influenza in China[J]. Zhonghua Yu Fang Yi Xue Za Zhi，2019，53（10）：1043-1048.
PAN X F，GRIFFITHS U K，PENNINGTON M，et al. Systematic review of economic evaluations of vaccination programs in mainland China：are they sufficient to inform decision making？[J]. Vaccine，2015，33（46）：6164-6172.
张海军，来晓真，吕韵，等. 我国肺炎球菌结合疫苗不同免疫策略的经济学评价研究系统综述[J]. 中国卫生经济，2022，41（2）：9-14.
FITZNER K A，SHORTRIDGE K F，MCGHEE S M，et al. Cost-effectiveness study on influenza prevention in Hong Kong[J]. Health Policy，2001，56（3）：215-234.
YOU J H，WONG W C，IP M，et al. Cost-effectiveness analysis of influenza and pneumococcal vaccination for Hong Kong elderly in long-term care facilities[J]. J Epidemiol Community Health，2009，63（11）：906-911.
YOU J H S，MING W K，CHAN P K S. Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong[J]. BMC Infect Dis，2014，14：618.
YOU J H S，MING W K，CHAN P K S. Cost-effectiveness of quadrivalent influenza vaccine in Hong Kong：a decision analysis[J]. Hum Vaccin Immunother，2015，11（3）：564-571.
LEUNG M K，YOU J H S. Cost-effectiveness of an in-fluenza vaccination program offering intramuscular and intradermal vaccines versus intramuscular vaccine alone for elderly[J]. Vaccine，2016，34（22）：2469-2476.
陈秀云，彭楚灵，陈秋莲，等. 中山市托幼儿童季节性流感疫苗接种效果及效益分析[J]. 公共卫生与预防医学，2016，27（4）：87-89.
WONG C，JIANG M H，YOU J H S. Potential cost-effectiveness of an influenza vaccination program offering microneedle patch for vaccine delivery in children[J]. PLoS One，2016，11（12）：e0169030.
杨亚兰，高钰琳，李丹丹，等. 老年糖尿病患者肺炎及流感疫苗接种情况及成本效益分析[J]. 临床护理杂志，2020，19（6）：2-4.
杜芳，王蒲生，黄琇棠，等. 深圳市65岁以上老年人群接种流感疫苗的成本-效果分析[J]. 中国卫生经济，2021，40（10）：74-78.
CHEN D Q，YE Z J，PI Z F，et al. Cost-effectiveness of dual influenza and pneumococcal vaccination among the elderly in Shenzhen，China[J]. Vaccine，2021，39（16）：2237-2245.
向蓥飞，周德谦，钟杰伟，等. 广州市越秀区托幼机构流感样病例暴发疫情经济负担评估和流感疫苗卫生经济学评价[J]. 华南预防医学，2021，47（10）：1231-1235.
DING H Y，HUANG J J，NGAI C H，et al. The cost-effectiveness of starting 23-valent pneumococcal polysaccharide vaccine and influenza vaccination at 50 vs. 65 years：a comparative modelling study[J]. Vaccine，2022，40（9）：1282-1288.
D’ANGIOLELLA L S，LAFRANCONI A，CORTESI P A，et al. Costs and effectiveness of influenza vaccination：a systematic review[J]. Ann Ist Super Sanita，2018，54（1）：49-57.
AU F，PRAHARDHIS，SHIELL A. Reliability of two instruments for critical assessment of economic evaluations[J]. Value in Health，2008，11（3）：435-439.
0
Views
4
下载量
0
CSCD
- L-PDFDownload
- WORDDownload
- Meta-XMLDownload
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Publicity Resources
Related Articles
Related Author
Related Institution
- Address：8/F,129 Daping Main Street,Yuzhong District,Chongqing 400042,P.R.China
- Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号
公网安备50010302001817 - It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
- Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.